Obesity has reached epidemic proportions and is a risk factor for fractures in both children and adults, despite higher DXA measures of areal bone mineral density (BMD). Roux-en-Y gastric bypass (RYGB) and vertical sleeve gastrectomy (VSG) are bariatric procedures that are increasingly used in adolescents. However, studies in adults suggest that accelerated bone loss may be a major metabolic complication of bariatric surgery. This is of particular concern during adolescence, a time of maximal bone accrual towards attainment of peak bone mass, a key determinant of future fracture risk. Although bariatric surgery in obese adolescents is becoming increasingly common, there is a major knowledge gap regarding consequences on bone in adolescents with commonly used bariatric procedures. Of note, the use of DXA in obesity and following weight loss is prone to artifactual inaccuracies and may not reflect true changes in bone strength. In contrast, quantitative computed tomography (QCT) and high-resolution peripheral QCT (HR-pQCT) avoid many limitations of DXA, and may yield critical insight about structural changes, and microfinite element analysis (FEA) provides non-invasive strength estimates. These methods have not been utilized to characterize bone changes in adolescents undergoing bariatric surgery. Recent developments have brought to light the bone-fat connection and the potential impact of marrow adipose tissue (MAT) in the pathogenesis of osteoporosis. However, the impact of bariatric surgery on MAT (measured in vivo using magnetic resonance spectroscopy (1H-MRS)) has not been studied in adolescents. Finally, an understanding of mechanisms that impact bone metabolism after RYGB and VSG could inform future therapies, and is lacking in adolescents. Our overall goal is to comprehensively evaluate skeletal health over 2 years in morbidly obese adolescents undergoing RYGB and VSG compared with matched non-surgical obese controls (Aim 1), and investigate mechanisms that contribute to deleterious changes in bone metabolism following bariatric surgery (Aim 2). Bone density will be assessed at the spine and hip by DXA and quantitative CT (QCT), and the whole body by DXA, before and for 2 years after RYGB and VSG, compared to matched non-surgical obese controls. We will evaluate biochemical markers of bone turnover and changes in bone microarchitecture at the radius and tibia (using HRpQCT) to ascertain how alterations in bone re/modeling and microarchitecture impact bone, and the implication of these changes for fracture risk by assessing changes in strength estimates (using FEA). Marrow fat will be assessed using 1H-MRS. Finally, we will evaluate complex interactions between bone, body composition and hormones that change with RYGB and VSG (insulin, ghrelin, peptide YY, estrogen) and may affect bone directly or via hormones such as sclerostin and Pref-1. We have assembled investigators with complimentary strengths for the proposal.

Public Health Relevance

The proposal will examine the impact of bariatric procedures (Roux-en-Y gastric bypass and vertical sleeve gastrectomy) on bone density, structure and strength over a two-year period in morbidly obese adolescents undergoing surgery compared to non-surgical obese adolescents. The proposal will also examine the predictors of changes in bone parameters in this population following surgery.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
3R01DK103946-01A1S1
Application #
9232919
Study Section
Skeletal Biology Structure and Regeneration Study Section (SBSR)
Program Officer
Malozowski, Saul N
Project Start
2015-08-06
Project End
2020-07-31
Budget Start
2015-08-06
Budget End
2016-07-31
Support Year
1
Fiscal Year
2016
Total Cost
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
073130411
City
Boston
State
MA
Country
United States
Zip Code
Palad, Carl J; Stanford, Fatima Cody (2018) Use of people-first language with regard to obesity. Am J Clin Nutr 108:201-203
Tauqeer, Zujaja; Gomez, Gricelda; Stanford, Fatima Cody (2018) Obesity in Women: Insights for the Clinician. J Womens Health (Larchmt) 27:444-457
Gomez, G; Stanford, F C (2018) US health policy and prescription drug coverage of FDA-approved medications for the treatment of obesity. Int J Obes (Lond) 42:495-500
Byrd, Angel S; Toth, Alexander T; Stanford, Fatima Cody (2018) Racial Disparities in Obesity Treatment. Curr Obes Rep 7:130-138
Singhal, Vibha; Torre Flores, Landy P; Stanford, Fatima C et al. (2018) Differential associations between appendicular and axial marrow adipose tissue with bone microarchitecture in adolescents and young adults with obesity. Bone 116:203-206
De Giuseppe, Rachele; Braschi, Valentina; Bosoni, David et al. (2018) Dietary underreporting in women affected by polycystic ovary syndrome: A pilot study. Nutr Diet :
Umoren, Olivia; Stanford, Fatima Cody (2018) Letter to the Editor Clin Nurse Spec 32:171
Kyle, Theodore K; Stanford, Fatima Cody; Nadglowski, Joseph F (2018) Addressing Weight Stigma and Opening Doors for a Patient-Centered Approach to Childhood Obesity. Obesity (Silver Spring) 26:457-458
Voss, Jameson D; Pavela, Greg; Stanford, Fatima Cody (2018) Obesity as a threat to national security: the need for precision engagement. Int J Obes (Lond) :
Bennett, Susan E; Schmitt, William P; Stanford, Fatima C et al. (2018) Case 22-2018: A 64-Year-Old Man with Progressive Leg Weakness, Recurrent Falls, and Anemia. N Engl J Med 379:282-289

Showing the most recent 10 out of 22 publications